» Authors » Lisa E M Hopcroft

Lisa E M Hopcroft

Explore the profile of Lisa E M Hopcroft including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 672
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Taylor K, Eastwood S, Walker V, Cezard G, Knight R, Arab M, et al.
Lancet Diabetes Endocrinol . 2024 Jul; 12(8):558-568. PMID: 39054034
Background: Some studies have shown that the incidence of type 2 diabetes increases after a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of the COVID-19...
2.
Brown A, Fisher L, Curtis H, Wiedemann M, Hulme W, Speed V, et al.
Br J Clin Pharmacol . 2024 Apr; PMID: 38589944
Aims: The COVID-19 pandemic created unprecedented pressure on healthcare services. This study investigates whether disease-modifying antirheumatic drug (DMARD) safety monitoring was affected during the COVID-19 pandemic. Methods: A population-based cohort...
3.
Cezard G, Denholm R, Knight R, Wei Y, Teece L, Toms R, et al.
Nat Commun . 2024 Mar; 15(1):2173. PMID: 38467603
Infection with SARS-CoV-2 is associated with an increased risk of arterial and venous thrombotic events, but the implications of vaccination for this increased risk are uncertain. With the approval of...
4.
Dawson A, Zarou M, Prasad B, Bittencourt-Silvestre J, Zerbst D, Himonas E, et al.
Nat Commun . 2024 Feb; 15(1):1090. PMID: 38316788
Macrophages are fundamental cells of the innate immune system that support normal haematopoiesis and play roles in both anti-cancer immunity and tumour progression. Here we use a chimeric mouse model...
5.
Lindsay L, Calvert C, Shi T, Carruthers J, Denny C, Donaghy J, et al.
Nat Commun . 2023 Aug; 14(1):5275. PMID: 37644002
Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate...
6.
Fisher L, Curtis H, Croker R, Wiedemann M, Speed V, Wood C, et al.
Elife . 2023 Jul; 12. PMID: 37498081
Background: The COVID-19 pandemic has had a significant impact on delivery of NHS care. We have developed the OpenSAFELY Service Restoration Observatory (SRO) to develop key measures of primary care...
7.
Rooney A, Hewins W, Walker A, Mackinnon M, Withington L, Robson S, et al.
Neurooncol Pract . 2023 May; 10(3):249-260. PMID: 37188163
Background: There are no effective treatments for brain tumor-related fatigue. We studied the feasibility of two novel lifestyle coaching interventions in fatigued brain tumor patients. Methods: This phase I/feasibility multi-center...
8.
Green A, Curtis H, Higgins R, Nab L, Mahalingasivam V, Smith R, et al.
BMJ Med . 2023 Mar; 2(1):e000276. PMID: 36936265
Objective: To ascertain patient eligibility status and describe coverage of antiviral drugs and neutralising monoclonal antibodies (nMAB) as treatment for covid-19 in community settings in England. Design: Retrospective, descriptive cohort...
9.
Oswald A, Symeonides S, Wheatley D, Chan S, Brunt A, McAdam K, et al.
Breast Cancer Res Treat . 2023 Mar; 199(1):35-46. PMID: 36859649
Purpose: The development of oestrogen resistance is a major challenge in managing hormone-sensitive metastatic breast cancer. Saracatinib (AZD0530), an oral Src kinase inhibitor, prevents oestrogen resistance in animal models and...
10.
Calvert C, Carruthers J, Denny C, Donaghy J, Hopcroft L, Hopkins L, et al.
Nat Commun . 2023 Jan; 14(1):107. PMID: 36609574
Evidence on associations between COVID-19 vaccination or SARS-CoV-2 infection and the risk of congenital anomalies is limited. Here we report a national, population-based, matched cohort study using linked electronic health...